Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer

被引:1
作者
Kang, Jaeku [1 ]
Kim, Sun Young [2 ,3 ]
机构
[1] Konyang Univ, Coll Med, Daejeon, South Korea
[2] Chungnam Natl Univ Hosp, Daejeon, South Korea
[3] Inst Canc Res, Internal Med, Daejeon, South Korea
关键词
D O I
10.1158/1538-7445.AM2011-5270
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5270
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Specific Activity of Class II Histone Deacetylases in Human Breast Cancer Cells
    Duong, Vanessa
    Bret, Caroline
    Altucci, Lucia
    Mai, Antonello
    Duraffourd, Celine
    Loubersac, Julie
    Harmand, Pierre-Olivier
    Bonnet, Sandrine
    Valente, Sergio
    Maudelonde, Thierry
    Cavailles, Vincent
    Boulle, Nathalie
    MOLECULAR CANCER RESEARCH, 2008, 6 (12) : 1908 - 1919
  • [22] Expression levels of histone deacetylases and acetylation of histone H4 and tubulin associated with breast cancer progression
    Suzuki, J.
    Chen, Y. Y.
    DeVries, S.
    Chan, L.
    Baehner, F. L.
    Benz, C. C.
    Waldman, F. M.
    Hwang, E. S.
    CANCER RESEARCH, 2009, 69 (02) : 171S - 172S
  • [23] Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
    Poyet, Cedric
    Jentsch, Bastian
    Hermanns, Thomas
    Schweckendiek, Daniel
    Seifert, Hans-Helge
    Schmidtpeter, Martin
    Sulser, Tullio
    Moch, Holger
    Wild, Peter J.
    Kristiansen, Glen
    BMC CLINICAL PATHOLOGY, 2014, 14
  • [24] Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer
    Legare, Stephanie
    Basik, Mark
    MOLECULAR ENDOCRINOLOGY, 2016, 30 (09) : 965 - 976
  • [25] Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases
    Barrett, Angela
    Santangelo, Samantha
    Tan, Keith
    Catchpole, Steve
    Roberts, Kevin
    Spencer-Dene, Bradley
    Hall, Debbie
    Scibetta, Angelo
    Burchell, Joy
    Verdin, Eric
    Freemont, Paul
    Taylor-Papadimitriou, Joyce
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (02) : 265 - 275
  • [26] Histone deacetylases: target enzymes for cancer therapy
    Mottet, Denis
    Castronovo, Vincent
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (02) : 183 - 189
  • [27] Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy
    Laschanzky, Richard S.
    Humphrey, Lisa E.
    Ma, Jihyun
    Smith, Lynette M.
    Enke, Thomas J.
    Shukla, Surendra K.
    Dasgupta, Aneesha
    Singh, Pankaj K.
    Howell, Gillian M.
    Brattain, Michael G.
    Ly, Quan P.
    Black, Adrian R.
    Black, Jennifer D.
    CANCERS, 2019, 11 (09)
  • [28] Histone deacetylases: target enzymes for cancer therapy
    Denis Mottet
    Vincent Castronovo
    Clinical & Experimental Metastasis, 2008, 25 : 183 - 189
  • [29] The role of histone deacetylases (HDACs) in human cancer
    Ropero, Santiago
    Esteller, Manel
    MOLECULAR ONCOLOGY, 2007, 1 (01) : 19 - 25
  • [30] The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
    Li, Guo
    Tian, Yuan
    Zhu, Wei-Guo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8